Andris A. Zoltners, Director at Adaptive Biotechnologies Corp (ADPT), sold 345,000 shares at $26.50 ($9.1M) on 2020-01-28, disclosed to the SEC on 2020-01-29.
Open-market sale of $9.1M ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.